Rachel Kleinman Rachel Kleinman Published May 22, 2025 Cigna has announced a deal to cap client copays on popular GLP-1 weight loss drugs by Eli Lilly and Novo Nordisk at $200 per month, a sum that would count toward a patient's deductible
While not a widely recognised side effect of GLP-1 medications, emerging evidence suggests potential links through neuroinflammation, altered pain modulation, and metabolic effects on nerve function
If you are a postmenopausal woman starting semaglutide and have any history of UTIs, discuss vaginal estrogen with your healthcare provider before UTIs become a recurring problem
Packaging Exposure to air, light, and heat can degrade your serum
There is no scientific consensus supporting immediate effects
In other words, better adherence leads to healthier patients who cost insurers far less over the long term